A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to treatment with immune checkpoint inhibitor drugs, investigators at the Johns ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, together with Alliance Foundation ...

Researchers at Duke University used CRISPR technologies to discover previously unannotated stretches of DNA in the 'dark genome' that are responsible ...

Younger donor age (18-35) is crucial for stem cell transplant success and patient survival; superseding related sibling matches and older donor paradigms.

Scientists at UCL and GOSH have used groundbreaking base-edited CAR‑T cell therapy — BE‑CAR7 — to treat aggressive T‑cell ...

The recent announcement by Philip Morris International that it is partnering with Ferrari to market its Zyn nicotine pouches on Formula 1 race cars shows the company is blowing smoke when it claims ...

By Dr. Liji Thomas, MD A new scientific review weighs natural and synthetic forms of vitamin B12, revealing where ...

One therapy wey pipo bin once reason as achievement for science fiction don reverse aggressive and incurable blood cancers ...

Worldwide Stablecoin Payment Network (WSPN), a leading provider of next-generation stablecoin infrastructure, today announced a strategic partnership with ArrivalX, a global digital payments and ...

Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in ...

Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) ...